Retraining Immune Cells To Kill Tumors
Immune cells called macrophages can destroy tumor cells by producing inflammatory proteins that are toxic to the tumor. But the environment inside the tumor somehow halts this production and instead causes the cells to make proteins that promote tumor growth.
Bush Administration Should 'Rethink' Immigration Detention Policies, Editorial States
The "skyrocketing rate" of immigrants to the U.S.
TELEHEALTH For Pulmonary Rehab
A program that delivers pulmonary rehabilitation via video-conferencing technology, the internet and other emerging technologies to patients who live too far from respiratory therapy centers to make the twice-weekly trip improves their clinical condition, outcome and quality of life in just eight wee.
Turning Back The Clock For Schwann Cells
Myelin-making Schwann cells have an ability every aging Hollywood star would envy: they can become young again. According to a study appearing in the May 19 issue of the Journal of Cell Biology, David B.
Multidisciplinary Research Tracks Influenza's Every Movement
It's the case of the missing flu virus. When the flu isn't making people sick, it seems to just vanish. Yet, every year, everywhere on Earth, it reappears in the appropriate season and starts its attack.
Harvard Antiabortion Group Asks Students To Seek Refunds For Portion Of Insurance Premium That Covers Abortions
The group Harvard Right to Life, or HRL, during the past two weeks has been sending cards to Harvard University students who have Blue Cross Blue Shield health insurance plans that detail how to request a refund for the portion of their premiums that funds abortions, The Politico reports.
Diagnosis At Earliest Stage For Majority Of Kidney Cancers
Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.
Genetic Test For Lung Cancer Recurrence?
The goal of developing reliable genetic tests to guide lung cancer treatment has taken a step forward. Researchers at Columbia University recently evaluated the ability of five high-risk genetic profiles, or signatures, to predict the likelihood that cancer would recur in patients whose non-small cell lung cancer was caught early and surgically removed.
Neural Cell Transplants May Help Those With Parkinson's Disease
The current issue of Cell Transplantation (Vol.
NARAL Experiences Criticism From Clinton Supporters After Endorsing Sen. Obama, The Politico Reports
The Politico on Monday examined some criticism directed toward NARAL Pro-Choice America from supporters of Democratic presidential candidate Sen. Hillary Rodham Clinton (N.Y.), as well as some state affiliates, after the group endorsed Sen. Barack Obama (D-Ill.